Showing results (231-240 of 1,612) with videos related to

Sort By:
Pageof 162
Expert Opinion on Biological Therapy|November 30, 2012
Contemporary use of bevacizumab in ovarian cancerTakahito M Miyake, Anil K Sood, Robert L Coleman
Cancer Research|February 25, 2010
The dicey role of Dicer: implications for RNAi therapyWilliam M Merritt, Menashe Bar-Eli, Anil K Sood
Expert Opinion on Biological Therapy|January 23, 2010
Farletuzumab in epithelial ovarian carcinomaWhitney A Spannuth, Anil K Sood, Robert L Coleman
American Journal of Obstetrics and Gynecology|April 4, 2007
Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancerWhitney A Spannuth, Premal H Thaker, Anil K Sood
Indian Journal of Pathology & Microbiology|January 1, 1994
Erythrocyte T-activation: clinical importance & recognition by a simple routine techniqueS Sethi, N Dhingra, N Madan, et al.
Nature Communications|September 4, 2014
Flocking at a distance in active granular matterNitin Kumar, Harsh Soni, Sriram Ramaswamy, et al.
Expert Opinion on Therapeutic Targets|November 23, 2005
EphA2 as a target for ovarian cancer therapyCharles N Landen, Michael S Kinch, Anil K Sood
Stroke|November 1, 1986
Familial hyperlipidemia in stroke in the youngB C Bansal, A K Sood, C B Bansal
Pageof 162